The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma
Abstract
ABSTRACT Hepatocellular carcinoma (HCC) continues to be a leading cause of cancer related death in the world. Conventional chemotherapeutic agents such as cisplatin (CDDP) have an unsatisfactory efficacy on HCC due to the poor response, severe toxicity and drug resistance. Curcumin (CUR) could improve the chemosensitivity of HCC to chemotherapy drugs by regulating a variety of signaling pathways. Herein, we describe a combination strategy using co‐loaded liposomes to effectively deliver and release CDDP and curcumin (CUR) to HCC for overcoming the unsatisfactory clinical outcome of CDDP monotherapy. In the study, CDDP and CUR co‐loaded liposomes (CDDP/CUR‐Lip) were prepared by a reverse microemulsion and film dispersion method and their average particle size 294.6±14.8nm with uniform size distribution. In vitro study showed that the nano sized CDDP/CUR‐Lip could synchronously release both CDDP and CUR to achieve the synergistic effect against HCC cells based on the optimal ratio (1:8) of both drugs. Compared with free drug or encapsulated mono‐drug therapy, CDDP/CUR‐Lip demonstrated the higher anti‐tumor activity in vitro against HepG2 cells with the IC50 of 0.62&mgr;M. In addition, CDDP/CUR‐Lip also increased intracellular ROS level during the HCC cells treatment. Furthermore, compared with single drug formulation, CDDP/CUR‐Lip showed the elongated retention time (t1/2=2.38h) and improved antitumor effect in both mouse hepatoma H22 and human HCC HepG2 xenograft models with reduced side effects. In conclusion, CDDP/CUR‐Lip provide an attractive and potential strategy to attain synergistic effect of CDDP and CUR for the treatment of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Cited by
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Liposomal delivery of natural product: A promising approach in health research
Islam Shishir, M. R., Karim, N., Gowd, V., Zheng, X., & Chen, W. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.01.013 · Cited by 178
Metadata
- Authors
- Cheng, Y., Zhao, P., Wu, S., Yang, T., Chen, Y., Zhang, X., He, C., Zheng, C., Li, K., Ma, X., & Xiang, G.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 545
- Issue
- 1-2
- Pages
- 261-273
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2802252398
- Cited by
- 171
- References
- 1
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.05.007
- The paper
- Cheng, Y., Zhao, P., Wu, S., Yang, T., Chen, Y., Zhang, X., He, C., Zheng, C., Li, K., Ma, X., & Xiang, G. (2018). Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.05.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.